Pharmaceuticals

Gelteq

Gelteq released FY2025 Q4 earnings on November 17 (EST), actual revenue USD 33.19K, actual EPS USD -0.1117

Gelteq released FY2025 Q3 earnings on November 17 (EST), actual revenue USD 31.98K, actual EPS USD -0.1077

Gelteq released FY2025 Annual Earnings on November 17 (EST), with actual revenue of USD 267.84K and EPS of USD -0.4667

Gelteq released FY2025 9 Months Earnings on November 17 (EST), actual revenue USD 236.36K, actual EPS USD -0.3592

Gelteq released FY2025 Semi-Annual earnings on June 30 (EST), actual revenue USD 204.52 K, actual EPS USD -0.2517

Gelteq released FY2024 Q2 earnings on June 30 (EST), actual revenue USD 26.2 K, actual EPS USD -0.0715

Gelteq released FY2025 Q1 earnings on June 30 (EST), actual revenue USD 107.52 K, actual EPS USD -0.1323

Gelteq released FY2024 Semi-Annual Earnings on June 30 (EST), actual revenue USD 51.12K, actual EPS USD -0.1396

Gelteq released FY2024 Q1 earnings on June 30 (EST), actual revenue USD 24.92K, actual EPS USD -0.068

Gelteq released FY2025 Q2 earnings on June 30 (EST), actual revenue USD 96.86K, actual EPS USD -0.1192

Gelteq released FY2024 Q4 earnings on November 15 (EST) with actual revenue of 21.28 KUSD and EPS of -0.0933 USD

Gelteq released FY2024 annual earnings on November 15, 2024 (EST) with actual revenue of 94.91K USD and EPS of -0.2913

CCSC Tech

Youlife

Core AI

Regentis Biomaterials

Epsium Enterprise

Autozi Internet Tech Global

Leslies

Mega Matrix

eLong Power

Smart Logistics Global

GELS

Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion | GELS Stock News

StockTitan

Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion | GELS Stock News

ARKG

IBBQ

STAA

SBIO

In Wednesday's after-market session, Staar Surgical (NASDAQ:STAA) led the gainers with a 19.7% increase to $25.0, followed by Healthcare Triangle (NASDAQ:HCTI) up 15.57% to $2.82. Other gainers included AVITA Medical (NASDAQ:RCEL) +12.19%, Talphera (NASDAQ:TLPH) +8.86%, Geovax Labs (NASDAQ:GOVX) +8.44%, and Modular Medical (NASDAQ:MODD) +7.84%. On the downside, Scienture Holdings (NASDAQ:SCNX) fell 8.2% to $0.32, with Zhengye Biotechnology (NASDAQ:ZYBT) down 8.12%. Other losers included RxSight (NASDAQ:RXST), Profusa (NASDAQ:PFSA), Impact BioMedical (AMEX:IBO), and Axe Compute (NASDAQ:AGPU).

benzinga_article

Ark Genomic Revolution ETF

Invesco Nasdaq Biotechnology ETF

Invesco Biotechnology & Genome ETF

STAAR Surgical

GeoVax Labs

SPDR S&P Biotech

Avita Medical

Proshares Ultra Nasdaq Biotech

Profusa

RxSight

VanEck Biotech ETF

ALPS Medical Breakthrough

Modular Medical

Direxion S&P Biotech Bull 3X

iShares US Medical Devices

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

Talphera

SPDR S&P Health Equip

Health Care Select Sector SPDR

VG Health

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gelum Changes Location of Annual General Meeting | GMRCF Stock News

Gelum Changes Location of Annual General Meeting | GMRCF Stock News

The global Collagen Peptide Market is projected to grow from USD 2.8 billion in 2026 to USD 7.0 billion by 2036, with a CAGR of 9.7%. The market is shifting towards precision-engineered bioactive peptides, driven by demand for clinical validation and functional nutrition. Bovine collagen leads the market, while Type I collagen is favored for its relevance to skin health. Key growth drivers include the rise of functional beverages and increasing consumer awareness of health benefits. Major players include GELITA and Darling Ingredients, focusing on quality and traceability to maintain competitive advantage.

MorningStar

Darling Ingredients

Collagen Peptide Market 2026-2036 | Europe & US Demand Surge with Top Companies GELITA, Darling Ingredients

Gelteq Warned by Nasdaq Over Minimum Bid Price Compliance

Tip Ranks

Gelteq Warned by Nasdaq Over Minimum Bid Price Compliance

HYEX

In a joint statement on February 11, 2026, Gelteq Limited and Healthy Extracts™ Inc. revealed the establishment of a strategic alliance through a Memorandum of Understanding. This partnership aims to expedite the market launch of innovative gel-based nutraceutical items. It follows Healthy Extracts' earlier acquisitions of Gelteq-developed products and signifies the initial stage in a comprehensive strategy to introduce Gelteq's exclusive gel delivery system to widespread US production and worldwide circulation.

Unusual Whales

Healthy Extracts Inc.

Gelteq and Healthy Extracts partner to expand gel-based nutrition technologies, focusing on US production and global distribution.

Gelteq(GELS.US)

Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion | GELS Stock News

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gelum Changes Location of Annual General Meeting | GMRCF Stock News

Collagen Peptide Market 2026-2036 | Europe & US Demand Surge with Top Companies GELITA, Darling Ingredients

Gelteq Warned by Nasdaq Over Minimum Bid Price Compliance

Gelteq and Healthy Extracts partner to expand gel-based nutrition technologies, focusing on US production and global distribution.